31 January 2022 | News
To encourage smaller labs that cannot afford high-end automation
Central Drugs Standard Control Organization (CDSCO) has approved two more important COVID-19 testing products of HiGenoMB – HiMedia Laboratories.
In the Hi-PCR COVID-19 Detection Kit-Dry Swab method (MBT189), the extraction free method assesses dry swab samples and supports direct real-time PCR post sample collection. This is an ideal solution to encourage smaller laboratories that cannot afford high-end automation and reduces dependency on skilled technicians to venture into molecular diagnostics.
The Hi-PCR COVID-19 Triplex Probe PCR Kit (MBPCR255) is a three gene multiplex PCR kit that can detect two target COVID genes, viz. (N) gene and RNA-dependent RNA polymerase (RdRp) gene along with an internal process control with maximum sensitivity. It is an alternative to our CDSCO approved four gene Hi-PCR Coronavirus (COVID-19) Probe PCR Kit (MBPCR243).
Visit www.himedialabs.com for more details about HiGenoMB® products related COVID Molecular testing.